Table 2.
Nanoparticle | Size | Role of Action | References |
---|---|---|---|
PLGA NPs | 350–410 nm | It provides immunotolerance to cancer. It was found to induce anti-tumor therapeutic effects. CD8 T cells secreted interferons at the site of lymph nodes and spleen, and vaccinated mice were treated with PLGA NPs. | [104] |
β-Glucan NPs (BG34-Fe3O4 conjugated carbon nanotubes) | 80–100 nm (Length) 10–20 nm (Diameter) |
β-glucan from the cell wall of natural sources such as plants and fungi, have appeared to enhance anti-tumor responses through direct interaction with immune cells such as macrophages and others. It acts as an immune modulator in optimizing tumor microenvironments. | [105] |
Anti-PD-L-1 targeted nanoplatform consists of Au-SPIO@PLGA NPs | 500 nm | It was found to achieve the promotion of polarization of TAM to M1 (classically activated macrophages) and reverse the cause of immunosuppression by TAM and block the programmed death-ligand 1/Programmed cell death pathway. | [106] |
F Conjugated–PLGA NPs | 500 nm | The efficient and specific T-cell targeting drug delivery binding system in vitro in human cells. In vivo, it allows specific targeted delivery of an inhibitor of TGFβR1 and TLR 7/8 agonist, found to delay the growth of tumors in mice, when delivered via Programmed cell death-1 protein targeting NPs. | [107] |
CD44TA-LIP NPs (Liposomes targeting CD44 receptor using Thioaptamers) | 204.9 | Found to exhibit a host defense mechanism against invading pathogens (TB immunopathogenesis) activate lymphocytes, and provide immunity against tuberculosis in mice. | [108] |
Zn-pyrophosphate NPs loaded with photosensitizer pyrolipid (Zn P@Pyro) | NA | It can kill tumor cells, induces apoptosis, and tumor-specific cytotoxic T-cell responses, and disrupt tumor vasculature. It significantly prevents the metastasis of tumors to the lungs of mice. | [109] |
PLGA NPs-based vaccine | 350–410 nm | It induces specific anti-tumor T-cell responses and activates INF-γ secretion at lymph nodes by activation of CD8+, TRP2 specific T-cells of vaccinated mice bearing melanoma B16 tumors. | [104] |
Cytosine-phosphate-guanine coated NPs | NA | It shows rapid accumulation by Antigen-presenting cells and triggers the release of cytokines (IL-10). Induces strong anti-inflammatory responses, enhances TH1/TH2 responses, and eliminates tumor cells. | [110] |
Nano-artificial APC iron-dextran coated NPs | 50–100 nm | It was found to enhance antigen-specific T-cell proliferation in vitro and inhibition/clearance of tumor growth | [111] |
Abbreviations: PLGA-Poly(lactic-co-glycolic acid), TAM (tumor-associated macrophage), CD (cluster of differentiation), Fab (fragment, antigen binding), Au (gold), and SPIO (superparamagnetic iron oxide).